ArticleACS omega2026
Balancing Strength and Cell Viability in Gelatin Methacrylate/Gellan Gum Bioink Formulations.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Progressing Regenerative Medicine: Integrating Bioprinting Platforms for Stem Cell Applications.Stem cells international · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Soft tissue injuries resulting from trauma or degeneration are challenging to treat due to limited regenerative capacity, particularly in complex tissues, such as the central nervous system (CNS), nerves, and cartilage, where biomechanical and biochemical factors hinder effective repair. In these cases, tissue engineering presents a promising approach by combining biomaterials, cells, and bioactive signals to enhance soft tissue regeneration; however, its success relies on the compatibility between implanted materials and native tissue. Among the advances in this field, 3D bioprinting enables precise spatial control of the scaffold architecture and cell positioning, making it well-suited for developing constructs that mimic native tissue. In this study, we developed and characterized a series of bioink formulations based on a dual network system of gelatin methacrylate (GelMA) combined with gellan gum (GG). The GelMA/GG hydrogels were evaluated using rheological and compression testing as well as biodegradation and cell viability assays, including live/dead fluorescence microscopy. Formulations containing two different concentrations of GelMA (2.5 and 4.0% w/w) and GG (0.25 and 0.50% w/w) were tested, and the rheological results showed a strong dependence of the elastic component (
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.